Trials / Withdrawn
WithdrawnNCT05024955
Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
Understanding Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the U.S.
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study better understands the views on shared decision-making among Chinese adults who smoke or who have a spouse who smokes. Lung cancer is the second most common cancer among men and women in the United States and is the number one cause of cancer-related mortality among Asians and Pacific Islanders. Clinicians are recommended to initiate conversations about lung cancer screening with eligible patients, provide information about the benefits and harms, and engage in shared decision-making. However, a patient's cultural background can influence decision-making in many ways. Given this, there is a need to understand the perceptions of shared decision-making among different populations (in this case, Asian populations) in order to inform the design of culturally sensitive decision aids for cancer screening. This study evaluates how Chinese populations in the U.S. who currently smoke or who have partners who smoke perceive the process of shared decision-making, their preferences, the perceived barriers and facilitators, and their perspective on currently-available screening tools.
Detailed description
PRIMARY OBJECTIVES: I. Understand how Chinese populations in the Unites States who currently smoke or who have partners who smoke perceive the process of shared health-related decision-making and their preferences in terms of role involvement, and the barriers to and facilitators of shared decision-making. II. Evaluate current publicly available lung cancer screening tools from the perspective of Chinese adults who smoke or who have partners who smoke. OUTLINE: Participants attend an interview over 45-60 minutes and/or a focus group over 1.5 to 2 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Discussion | Attend a focus group |
| OTHER | Interview | Attend interview |
Timeline
- Start date
- 2021-07-20
- Primary completion
- 2024-03-08
- Completion
- 2024-03-08
- First posted
- 2021-08-27
- Last updated
- 2024-03-15
Source: ClinicalTrials.gov record NCT05024955. Inclusion in this directory is not an endorsement.